School of Medicine
Showing 2,501-2,600 of 5,184 Results
-
Curtis Langlotz
Senior Associate Vice Provost for Research, Professor of Radiology (Integrative Biomedical Imaging Informatics), of Medicine, of Biomedical Data Science and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsMy laboratory develops machine learning methods to help physicians detect disease and eliminate diagnostic errors. My laboratory is developing neural network systems that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report for contrastive learning and other multi-modal methods that improve the accuracy and capability of machine learning systems.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health and, by courtesy, of Urology
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Benjamin Laniakea
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award.
-
Maarten Lansberg, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.
-
Patrick Lanter
Clinical Assistant Professor, Emergency Medicine
BioPATRICK LANTER, MD, MPH FACEP is an assistant professor in the Department of Emergency Medicine at Stanford University. Dr. Lanter previously completed a 2-year ultrasound fellowship and 2-year global emergency medicine at Stanford and has completed his master's in public health at the University of California Berkeley. He completed his emergency medicine residency at Washington University in St. Louis where he served as Chief Resident. He completed his medical school training at the University of Illinois, Chicago and was a member of the Global Medicine Program during his time there. His work has focused on the development of a sustainable ultrasound training program at the University Teaching Hospital of Kigali in Rwanda. Additionally, he has served as a course instructor for 2 Stanford courses (Medical Student Introduction of POCUS and Point of Care Ultrasound Clerkship), and the Emergency Medicine Clerkship at the University of Global Health Equity in Butaro, Rwanda.
-
Tobias Lanz
Assistant Professor of Medicine (Immunology and Rheumatology)
BioTobias Lanz, MD is an Assistant Professor at the Institute for Immunity, Transplantation, and Infection and the Division of Immunology and Rheumatology at Stanford. His research focuses on B cell biology in neuroimmunological diseases and rheumatic diseases with neurological manifestations. He uses high-throughput screening technologies, and methods from structural and cell biology to identify new autoantigens and to understand how certain self-reactive B cells escape tolerance mechanisms. He is particularly interested in molecular mechanisms that explain the association between Epstein Barr Virus (EBV) and autoimmunity.
Tobias went to medical school at the Eberhard Karls University in Tübingen, Germany and at the University College of London. He wrote his MD thesis at Dr. Michael Platten's laboratory at the Hertie Institute for Clinical Brain Research in Tübingen, Germany before joining Dr. Lawrence Steinman’s neuroimmunological laboratory at Stanford as a research scholar. After medical school he pursued his scientific and clinical training at the German Cancer Research Center (DKFZ) and the Department of Neurology at the University Hospital in Heidelberg, Germany. In 2015 he joined Dr. William Robinson’s lab at Stanford, where he investigated environmental triggers of autoimmunity, including viruses and milk consumption. In his most recent work, he characterized the B cell repertoire in the spinal fluid of patients with multiple sclerosis (MS) and identified molecular mimicry between EBV EBNA1 and the glial cellular adhesion molecule GlialCAM as a driver of neuroinflammation (Lanz et al., Nature, 2022). His long term objective is to leverage these newly discovered mechanistic insights to develop next-generation biomarkers and therapeutics for autoimmune diseases. -
Bryan Lanzman, MD
Clinical Associate Professor, Radiology
BioDr. Bryan Lanzman completed his medical degree and radiology residency at Columbia University Medical Center, before coming to Stanford University for a 2-year Neuroradiology fellowship. He joined the faculty at Stanford in 2017 and is actively involved in medical student and resident education, as well as quality improvement efforts within the neuroradiology section. He also serves as a co-director of the Neuroradiology clerkship for medical students, and for the Neuroradiology elective for neurology residents.
-
Nicholas Wiessner Larsen, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Larsen is a clinical assistant professor in the Department of Neurology, Division of Autonomic Disorders. He is a board-certified neurologist and a fellowship-trained specialist in neurophysiology and autonomics. He completed medical school at the University of Utah and neurology residency and fellowship at Stanford.
In his clinical practice, Dr. Larsen focuses on disorders of the autonomic nervous system (ANS). His research interest is in the long-term autonomic complications of COVID-19. He is the principal investigator of a study looking at post-COVID postural tachycardia syndrome.
Dr. Larsen’s research interests also include Global Health Neurology. Dr. Larsen helped establish the first stroke unit in Rwanda and is part of the American Academy of Neurology’s Refugees & Asylum Seekers Working Group.
He has co-authored articles for publication in Clinical Autonomic Research, Autonomic Neuroscience, Nature Climate Change, and elsewhere. He is a recipient of the American Academy of Neurology Medical Student Prize for Excellence as well as a member of the Alpha Omega Alpha Honor Medical Society. -
David Larson
Professor of Radiology (Pediatric Radiology)
BioDavid B. Larson, MD, MBA, is Professor of Radiology (Pediatric Radiology) in the Department of Radiology at Stanford University. His career is focused on managing and improving complex sociotechnical healthcare systems to drive continuous operational improvement for the benefit of patients and clinicians. His research and leadership activities span the sociotechnical spectrum, from the development of process control systems that optimize CT radiation dose to transitioning the field of radiology from "peer review" toward "peer learning" to foster a more collaborative and constructive work environment.
He has founded and directed numerous improvement programs at Stanford and beyond, including Stanford’s Realizing Improvement through Team Empowerment (RITE) program, the Clinical Effectiveness Leadership Training (CELT) (program co-founder), Stanford Medicine's Improvement Capability Development Program (ICDP), and the Stanford Medicine Center for Improvement's (SMCI's) Advanced Course in Improvement Science (ACIS). He is also the founder and co-director of the American College of Radiology's (ACR's) Learning Network, its various Improvement Collaboratives, and the ImPower improvement training and project support program.
Dr. Larson served for over 10 years in various senior leadership roles in the Stanford Department of Radiology, including Associate Chair for Performance Improvement, Vice Chair for Education and Clinical Operations, Executive Vice Chair, and Acting Chair. He currently serves as the Director of the Stanford Radiology AI Development and Evaluation (AIDE) Lab. He also serves as the Medical Director of Performance Improvement at Stanford Health Care.
Dr. Larson has applied his experience to advance the thinking and application of systematic improvement methods in the field of radiology. He is the founder and program chair for the annual Radiology Improvement Summit held annually at Stanford, which began in 2016. He serves on the Board of Trustees of the American Board of Radiology, overseeing quality and safety, and recently completed a 6-year term on the Board of Chancellors for the American College of Radiology as the chair of the ACR's Commission on Quality and Safety. He currently serves as the Vice President of the American College of Radiology.
Prior to his position at Stanford, Dr. Larson was the Janet L. Strife Chair for Quality and Safety in Radiology and a faculty member of the James M. Anderson Center for Health Systems Excellence at Cincinnati Children’s Hospital in Cincinnati, Ohio. He holds MD and MBA degrees from Yale University and completed his pediatric internship and radiology residency and fellowship at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Larson practices clinically at Lucile Packard Children's Hospital at Stanford. -
Ruth Lathi, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsRecurrent miscarriage, genetic and other causes of miscarriage, preimplantation genetic diagnosis, effects of fertility treatments on androgen levels in early pregnancy and how fertility diagnosis and treatments affect pregnancy outcomes.
-
Amira Latif Hernandez
Instructor, Adult Neurology
BioAmira obtained her Ph.D. in Neuroscience from the KU Leuven, Belgium, in summer 2017. During her doctoral studies, she used clinically valid tests of murine cognition, neuronal plasticity measures in hippocampal and cortical slices, brain lesion methods, pharmacological applications and resting state functional magnetic resonance imaging to characterize the pathophysiology of novel mouse models of Alzheimer’s disease (AD). One of her most gratifying contributions was the development of a new electrophysiology tool to assess synaptopathies, and the establishment of long-term synaptic plasticity from prefrontal cortex of APP knock-in mice. In Autumn 2017, she moved to Dr. Longo’s lab at the Stanford School of Medicine, where she investigates signaling pathways involved in synaptic degeneration. During 3 years of postdoctoral work, she established a multi-electrode array system with eight independent recording chambers that allows high-throughput analyses of multiple long-lasting forms of synaptic plasticity. She also gained experience in RNA-sequencing, molecular biochemistry, signaling mechanisms, target validation and drug development strategies for AD. In October 2020, Amira has been appointed as an Instructor in Neurodegenerative Disease Research, in the Longo lab, to help develop improved and more powerful approaches that will better reveal key synaptic mechanisms and candidate modules associated with neuroplasticity and affected in AD mouse models, by identifying activity-dependent gene expression signatures.
-
Philip W. Lavori
Professor of Biomedical Data Science, Emeritus
Current Research and Scholarly InterestsBiostatistics, clinical trials, longitudinal studies, casual inference from observational studies, genetic tissue banking, informed consent. Trial designs for dynamic (adaptive) treatment regimes, psychiatric research, cancer.
-
Rondy Michael Lazaro, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Rondy Michael Lazaro is a board-certified, fellowship-trained physiatrist with specialization in sports medicine in the Stanford Health Care Physical Medicine and Rehabilitation Division. He is also a clinical assistant professor in the Department of Orthopaedic Surgery, Division of Physical Medicine and Rehabilitation at Stanford University School of Medicine.
Dr. Lazaro’s clinical expertise includes diagnosing and treating a wide range of sports medicine conditions. His clinical practice focuses on injuries and conditions of the lower extremity (hip, knee, ankle, and foot). He is an expert in using ultrasound to diagnose musculoskeletal injuries and perform ultrasound-guided procedures. Dr. Lazaro is experienced with treating injuries in runners and other endurance athletes. He is also well-versed in taking care of performing artists such as dancers and musicians.
He has extensive experience providing medical coverage for high school, collegiate, and professional athletic events and teams. He was a lead venue physician for the 2023 World University Games in Lake Placid, New York. He also served as company physician for New York State Ballet.
His research focuses on evidence-based approaches to prevent injury, relieve pain, and optimize health and performance. Organizations such as the American Medical Society for Sports Medicine (AMSSM) have supported his work with grant funding.
Dr. Lazaro has been published in journals such as The Knee and Clinical Journal of Sports Medicine. He has presented his findings at national and international conferences, including the annual meetings of the Association of Academic Physiatrists and the AMSSM.
Dr. Lazaro is an active member of several professional societies, including the American College of Sports Medicine and the International Association for Dance Medicine & Science. He also serves on committees for the AMSSM and the Performing Arts Medicine Association. He is a fellow of the American Academy of Physical Medicine and Rehabilitation.
Dr. Lazaro is originally from Hayward, California. He graduated from Stanford University with a BA in Music (concentration in Conducting) and BS in Biology. He earned his MD from the University of Virginia School of Medicine. He completed his internship in Internal Medicine at Alameda Health System/Highland Hospital. He then completed his residency in Physical Medicine and Rehabilitation at Virginia Commonwealth University, followed by a fellowship in Sports Medicine at Virginia Commonwealth University and Bon Secours St. Francis Medical Center. -
Shelby Scott Lazarow, Psy.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Lazarow is a licensed psychologist who specializes in providing clinical care for individuals and couples dealing with acute and chronic medical conditions. She received her doctorate in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium and completed her clinical internship and postdoctoral fellowship at California Pacific Medical Center in the Health Psychology track. Dr. Lazarow is currently serving patients of the Neuropsychiatry Clinic at Stanford University's School of Medicine. In addition to providing individual and couples therapy, Dr. Lazarow has created multiple therapy groups specifically designed for individuals dealing with neurological conditions.
-
Laura C. Lazzeroni, Ph.D.
Professor (Research) of Psychiatry and Behavioral Sciences, Emerita
BioA key signatory of the Great Barrington Declaration against the Covid lockdowns,before publication on October 5, 2020.
-
Quynh-Thu Le, MD, FACR, FASTRO, FARS
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsMy laboratory focuses on identifying pathways and biomarkers of treatment resistance in head and neck cancer using clinical samples. We explore approaches to modulate these pathways through preclinical models (cell lines, organoids, tumor bearing mice) in order to develop precise strategies against these resistant mechanisms. At the same time, we are also studying pathways involved in treatment-related toxicity and develop strategies to prevent or overcome these toxicities.
-
Scheherazade Le, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsNeurophysiology, Epilepsy/EEG, Intraoperative Neurophysiologic Monitoring,Tuberous Sclerosis, Autoimmune Epilepsy/Encephalitis, Autoimmune Encephalitis, Immune-Mediated Epilepsy
-
Melanie Lean
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMelanie Lean, Clin.Psych.D. is a Californian licensed clinical psychologist, Clinical Assistant Professor, and assistant director of research in the INSPIRE early psychosis clinic, Stanford University School of Medicine. She provides Cognitive Behavioral Therapy for psychosis (CBTp) within the recovery oriented and trauma informed framework of the INSPIRE clinic. Dr Lean received her doctorate from University College London, UK and completed her postdoctoral fellowship at Stanford University. She is a mixed methods researcher, with over 15 years’ experience in mental health research, working across a range of settings with a focus on severe and enduring mental illness and ways to improve service provision for this population. She has specialized knowledge in self-management and peer support interventions for people with psychosis and has experience working alongside service user researchers in the evaluation and delivery of study interventions. Dr Lean is also trained in psychedelic assisted therapy and works on a range of clinical trials investigating psilocybin for treatment resistant depression.
-
Hayley Wheeler Leatham, MD
Clinical Assistant Professor, Dermatology
BioDr. Leatham is a dermatologist and clinical assistant professor in the Department of Dermatology at Stanford University School of Medicine. Her clinical interests include the prevention and treatment of skin cancer, acne, psoriasis, and dermatologic surgery, as well as the full range of general dermatologic skin conditions.
Dr. Leatham’s research interests include the relationship between interferon expression, clinical characteristics, and prognosis in patients with dermatomyositis. She has co-authored articles on clinical factors associated with this condition, as well as other subjects such as blistering dermatosis as a sign of multiple myeloma relapse. Her work has appeared in the Journal of Cutaneous Pathology, Journal of the American Academy of Dermatology Case Reports, Medicine, and other journals.
Presentations by Dr. Leatham have addressed cutaneous coccidioidomycosis and a range of dermatomyositis-related topics, including interferon activity and malignancy screening outcomes. She has delivered these presentations at the annual meetings of the American Academy of Dermatology, Rheumatologic Dermatology Society, American College of Rheumatology, and Society of Investigative Dermatology.
During medical school, Dr. Leatham was honored to be selected into the Stanford Gold Humanism Honor Society for demonstrating excellence in clinical care, leadership, compassion, and dedication to service. She was also inducted into the Alpha Omega Alpha medical honor society during her chief resident year.
Her community service activities include volunteering for SUNSPORT, the Stanford University Network for Sun Protection, Outreach, Research, and Teamwork, the most comprehensive sun protection outreach and research program of any university in the nation. This initiative provides risk awareness and sun protection education to Stanford outdoor athletes and fans, as well as all students, faculty, and staff. It is a collaborative effort of the Stanford Department of Dermatology, Stanford Cancer Institute, Stanford Hospital & Clinics, and Stanford Athletics. -
Alice A. Lee
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Lee's research focuses on the early detection of pancreatic cancer, including the investigation of risk factors for pancreatic cancer and biomarkers to detect early cancer.
-
Anson M. Lee, MD
Associate Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)
BioDr. Anson M. Lee is a board-certified, fellowship-trained cardiothoracic surgeon with Stanford Health Care. He is also an associate professor in the Department of Cardiothoracic Surgery, Division of Adult Cardiac Surgery at Stanford University School of Medicine.
Dr. Lee specializes in treating all types of heart disease, such as blocked arteries, structural and valve issues, and aortic conditions. He has a special interest in treating abnormal heart rhythms (arrhythmias) and performing advanced procedures, such as video-assisted thoracoscopic hybrid ablation for difficult-to-treat atrial fibrillation. He uses minimally invasive techniques whenever possible to reduce risk and ease recovery for his patients.
In addition to patient care, Dr. Lee is a dedicated heart researcher. His recent studies have focused on optimizing treatment for atrial fibrillation, heart and lung transplantation, and valve disease, as well as improving organ preservation for lung transplantation. He is one of only a few cardiothoracic surgeons in the world publishing research on hybrid ablation and has built a leading hybrid ablation center in collaboration with Stanford Medicine electrophysiologists.
Dr. Lee has published his findings in leading medical journals, such as The Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery. He participates in drafting clinical guidelines and currently serves on the Cardiac Clinical Practice Standards Committee of the American Association for Thoracic Surgery (AATS). He has also written several book chapters on cardiac surgery techniques, complications, and innovations. He regularly shares his research and expertise around the world, from presenting at the American Heart Association (AHA) Scientific Sessions to speaking at the AATS Foundation programs and symposiums in Thailand and China.
Dr. Lee is a member of the prestigious AATS. He is also a member of the AHA and the Society of Thoracic Surgeons. -
Bomi Lee
Assistant Professor of Pediatrics (Gastroenterology, Hepatology, and Nutrition)
Current Research and Scholarly InterestsMy lab is dedicated to unraveling the complexities of the immune microenvironment and its role in the pathogenesis of pancreatic diseases, such as pancreatitis and pancreatic cancer. By leveraging cutting-edge technology, innovative experimental and genetic animal models, as well as human specimens from donors, we aim to identify novel immune markers and potential therapeutic targets. Our goal is to advance the understanding of immune cells and their contributions to these diseases and to transl
-
Byrne Lee, MD FACS
Clinical Professor, Surgery - General Surgery
BioDr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.
Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.
Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries. -
Byron Lee
Professor of Medicine (Cardiovascular)
BioDr. Byron Lee is Professor of Medicine in the Stanford Division of Cardiovascular Medicine and Cardiac Electrophysiology Section. He has published over 150 peer reviewed articles and 10 book chapters. He has written two books to help students navigate the medical school admission process: Insider's Premed Guidebook and Insider's High School Premed Guidebook. His research team studies treatments to prevent sudden cardiac death, atrial fibrillation, and complications of cardiac device lead extraction. He has won numerous teaching awards for his work with medical students, residents, and fellows. He currently teaches cardiovascular medicine and ECG reading at Stanford Medical School in the Practice of Medicine INDE 202, INDE 203, INDE 204 and INDE 205 courses. He also serves as Chief of Cardiac Electrophysiology at the Palo VA Medical Center and Head Cardiologist for University of California Athletics.
-
Chaw Ning Lee
Clinical Instructor, Dermatology
BioDr. Chaw-Ning Lee is a dermatologist and completed her dermatology education at National Cheng Kung University and Hospital and is a member of Taiwan Dermatology Association and Taiwanese Society for Investigative Dermatology. She earned her Ph.D. in pharmacoepidemiology and has experience in real-world evidence and Phase IV post-marketing studies using large databases. Since November 2023, Dr. Lee has been a visiting scholar in Program in Epithelial Biology and Pediatric Dermatology, Department of Dermatology at Stanford University. Her areas of special interest include skin cancer, pharmacoepidemiology, psoriasis, pediatric dermatology and drug eruptions.
-
David Lee, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1. Novel treatments and devices for the treatment of valvular disease
2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3. Novel approaches to coronary revascularization
4. Closure devices for atrial septal defects and patent foramen ovale
5. Novel treatments for hypertension -
Grace Eun Lee, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGrace Lee, Ph.D. is a Clinical Assistant Professor and a CA Licensed Clinical Psychologist in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Lee specializes in evidence-based, trauma-informed, and culturally-responsive care for individuals presenting with psychosis and post-traumatic stress. She is currently providing Cognitive Behavioral Therapy for Psychosis (CBTp), Cognitive Processing Therapy (CPT), Prolonged Exposure Therapy (PE), Narrative Exposure Therapy (NET), and Written Exposure Therapy (WET) within the INSPIRE Clinic and PTSD Clinic. She also leads national and international trainings in CBTp to providers supporting individuals with psychosis.
-
Grace Lee
Professor of Pediatrics (Infectious Diseases)
BioDr. Grace Lee is Chief Quality Officer and the Christopher G. Dawes Endowed Director of Quality at Stanford Medicine Children’s Health and Lucile Packard Children’s Hospital Stanford, and Associate Dean for Maternal and Child Health (Quality and Safety) and Professor of Pediatrics at Stanford University School of Medicine. She oversees the Center for Pediatric and Maternal Value that seeks to improve quality, safety, patient experience and health equity across the organization. Dr. Lee previously served as a member of the Institute of Medicine Committee (IOM) to Review Priorities in the National Vaccine Plan, the IOM Committee on the Ethical and Scientific Issues in Studying the Safety of Approved Drugs, the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response, and AHRQ's Healthcare Safety and Quality Improvement Research Study Section. She also served as a Board Member for the Society for Healthcare Epidemiology of America (SHEA), Pediatric Infectious Diseases Society (PIDS), and the National Academy of Medicine (NAM) Board on Population Health and Public Health Practice. She was previously the Chair of the U.S. Advisory Committee on Immunization Practices (ACIP) that recommends vaccines for the U.S. population, and she is an elected member of the National Academy of Medicine.
-
Jake J. Lee, MD
Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
BioDr. Lee is a fellowship-trained head and neck surgical oncologist with Stanford Medicine Cancer Center’s Head and Neck Cancer Program. He is also a clinical assistant professor in the Department of Otolaryngology—Head & Neck Surgery at Stanford University School of Medicine.
He treats benign and malignant tumors of the head and neck, including oral cancer, tonsil cancer, throat cancer, and thyroid cancer. As a result of his fellowship training, he also specializes in minimally invasive transoral surgery, organ preserving laryngeal surgery, and microvascular free flap reconstruction. Microvascular free flap reconstruction involves moving a piece of tissue, with blood vessels included, to a different part of the body to preserve function after cancer therapy.
Dr. Lee’s research interests include assessment of head and neck cancer treatment outcomes and development of patient-reported outcome measures (PROMs) in order to optimize form and function. He has also studied new therapies for smell and taste loss, including the design and implementation of randomized controlled trials (RCTs).
He has published in several peer-reviewed journals, including JAMA Otolaryngology—Head & Neck Surgery, Head & Neck, Otolaryngology—Head and Neck Surgery, and Laryngoscope. He has presented to his peers at international, national, and regional meetings, including the annual meetings of the American Head and Neck Society (AHNS), American Rhinologic Society (ARS), and the American Academy of Otolaryngology—Head & Neck Surgery (AAO-HNS).
Dr. Lee is a member of the AHNS, AAO-HNS, and Triological Society. He has previously served as the chair of the AAO-HNS Foundation Section for Residents and Fellows-in-Training. -
Jason T. Lee, MD
Professor of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsDr. Lee is the Principal Investigator on several clinical trials examining therapeutic strategies for management of complex aortic aneurysm disease as well as aortic dissection.
Dr. Lees clinical interests include:
Endovascular repair of abdominal/thoracic aneurysms and dissections
Fenestrated and Branch Repair of the thoracic, thoracoabdominal, and abdominal aneurysms
Carotid stenting
Thoracic outlet syndrome
Vascular disorders in high-performance athletes -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a healthcare lead and physician scientist for innovation, R&D, and advanced analytics, and oversee these aspects at VA Palo Alto/VHA, within Stanford-VA relationship. The VA has the US's largest health care system and longest running EHR. I prioritize enabling multiple partners (industry, government, academia, foundations), to innovate/R&D in the VA health care system. We prioritize mentoring students from various Schools to become future leaders in R&D, innovation, and healthcare.
-
Jennifer Y Lee, MD
Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)
Current Research and Scholarly InterestsDevelopment of treatment outcomes of Eustachian tube balloon dilation
-
Jin Hyung Lee
Associate Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery and of Bioengineering and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsIn vivo visualization and control of neural circuits
-
Jinwoo Lee, MD, PhD, FAAD
Instructor, Dermatology
BioDr. Jinwoo Lee is a physician-scientist and board-certified dermatologist on the clinical faculty in the School of Medicine. He received his B.S. in biology from Caltech and his M.D./Ph.D. from the UCSF Medical Scientist Training Program. Dr. Lee completed his residency in dermatology at Stanford, where he joined the Investigative Training Track to conduct basic science research in autoimmunity and inflammation. Dr. Lee’s scientific research focuses on identifying the mechanisms underlying the onset and progression of autoimmune diseases. His clinical interests include medical management of complex dermatologic conditions, autoimmune skin diseases, as well as general dermatology.
Dr. Lee is currently only seeing patients on Monday afternoons at the Stanford Medicine Outpatient Center in Redwood City. -
Jon B. Lee, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Assistant Professor, Emergency MedicineBioDr. Lee is board-ceritfied in emergency medicine, pain medicine, and addiction medicine. He works clinically as pain medicine and emergency medicine specialist at Stanford University.
Dr. Lee offers employs multi-modal medication utilization, injection therapies, radiofrequency ablation, and neuromodulation, to help patients manage their pain and improve their quality of life. Dr. Lee’s academic interests include interventional pain management in acute care settings, ED utilization and management for acute and chronic painful conditions, and transitions of care between inpatient and outpatient settings. He is actively involved in medical education, including programs for national pain conferences, focusing on training acute care providers in evidence-based, opioid-sparing approaches to pain management. -
Jonathan Lee (@ jonlee112)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioClincal:
Dr. Jonathan Lee, MD, PhD (@ jonlee112) is a Clinical Assistant Professor of Psychiatry and Behavioral Sciences at the Depression Clinic of Stanford University where he founded the "Am I Good? Examining life through the lenses of Philosophical Skepticism, Moral Philosophy, and Existentialism" philosophical psychotherapy group.
Jonathan Lee, MD, PhD (@ jonlee112) practices psychiatry, including psychotherapy, at Stanford University. He utilizes psychopharmacology alongside a particular approach to philosophical therapy, which he has termed ‘Decompositionism‘. Decompositionism is an approach to philosophical psychotherapy, developed by Jonathan Lee, MD, PhD (@ jonlee112), which is informed by knowledge from neuroscience, psychology, and philosophy…
Epistemology, Skepticism
Metaphysics, Ontology
Philosophy of Language
Philosophy of Mind
Moral Philosophy, Metaethics
Existentialism
…Decompositionism revolves around the use of analytical approaches aimed at decomposing cognitive concepts (words, phrases, thoughts, ideas, emotions, beliefs, etc) into their most fundamental components or features. Jonathan Lee, MD, PhD (@ jonlee112) designed Decompositionism to examine fundamental questions such as:
What is truth? What is reality? How do we know what we know? How do our brains/minds learn?
What actually exists in the universe?
What do we mean by the words, phrases, and concepts that we invoke in daily life?
What is right vs. wrong? What are our moral obligations?
What is good vs. bad?
What is the meaning of life? What is the point of life? What is the purpose of life?
Does free will exist?
Research:
His research focuses on the causes and consequences of, as well as solutions to, rising skepticism and distrust in sources of expert information (e.g., science, health). He has a special interest in exploring skepticism and persuasion at the intersection of health and politics, which includes studying phenomena such as the politicization of science and health, political polarization, filter bubbles/echo chambers, the emerging post-truth world, and information warfare. It also includes seeking heteorgeneity in the findings across particular demographics at high socioeconomic and health risk. He draws on theories and methods from his uniquely interdisciplinary set of educational, research, and professional experiences, including those from experimental and behavioral economics, political science, psychology, philosophy, and machine learning. He is currently using machine learning-based text analytics to explore how trust/distrust in sources of expert information is discussed on traditional and social media -- followed by the use of online randomized controlled survey experiments to test the causal effects of particular persuasion strategies on perceptions of trust/distrust, as well as other important behavioral outcomes of interest. -
Julie Jung Hyun Lee
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Julie J. Lee is a board-certified physician in Internal Medicine, Obesity Medicine, and Clinical Informatics at Stanford, where she works at the intersection of technology, precision health, and real-world clinical care.
As Health Equity Informaticist in Stanford's Division of Primary Care and Population Health, she leads data-informed strategies to evaluate and integrate digital health tools into clinical environments. Her work spans AI in healthcare, remote patient monitoring, patient portal communication, and clinical decision support, with a focus on ensuring these tools are clinically grounded, operationally feasible, and built around how patients and clinicians actually work. She advises industry and innovators on what it takes to move from promising technology to real-world impact.
Her clinical practice centers on obesity medicine and cardiometabolic health, where she applies precision and individualized approaches to challenge one-size-fits-all frameworks. She advocates for moving beyond outdated BMI-driven care toward more meaningful measures such as body composition, while helping build evidence that better reflects the diversity of patients, including Asian and Native Hawaiian and Pacific Islander communities.
Health equity and ethics shape how she approaches research, clinical care, and technology evaluation. As a physician who speaks both the language of medicine and the language of technology, Dr. Lee is interested in designing healthcare systems that strengthen clinical reasoning, improve communication between patients and clinicians and across interprofessional care teams, and ensure technology enhances the human practice of medicine. -
Sandra Soo-Jin Lee, Ph.D
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsDr. Lee is a medical anthropologist whose research focuses on the sociocultural dimensions and ethical issues of emerging technologies and their translation into clinical practice. Dr. Lee leads studies on the public understandings of research using clinical data and biological samples, concepts of race, culture and human genetic variation, and citizen science, commercialization of biotechnology and entrepreneurship.
-
Seolhyun Lee, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Lee is a nephrologist and Clinical Assistant Professor in the Nephrology Division of the Stanford Department of Medicine.
He delivers expert, compassionate kidney care personalized to each patient he serves. Dr. Lee is committed to improving both the health and quality of life of his patients.
His work scholarship has appeared in the Journal of the American Society of Nephrology, Kidney Week, and Blood Purification.
Dr. Lee has received honors and awards including the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology. The program funds original research projects by nephrology fellows. -
Christopher Lee-Messer, MD, PhD
Clinical Associate Professor, Pediatric Neurology
Clinical Associate Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsMy chief clinical focus is in pediatric epilepsy, especially how epilepsy affects learning and development. For my research, I background in neural development and computational neuroscience towards developing better learning algorithms and applying the latest techniques in machine learning for better diagnosis and treatment of disease.
-
John Leikauf
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsI am interested in better understanding the heterogeneous cognitive and electrophysiological abnormalities in children with ADHD and the many other conditions that commonly co-occur with ADHD. The long-term goal is to be able to better target treatments to specific deficits in order to promote long-term health and well-being and improve outcomes that matter to individuals and families suffering from these disorders.
-
Ramrada Lekwuttikarn MD
Clinical Instructor, Dermatology
BioRamrada Lekwuttikarn, MD is a pediatric dermatologist and clinical investigator in the Division of Pediatric Dermatology at Stanford University School of Medicine and Lucile Packard Children’s Hospital. She serves as a Research Scientist and Clinical Instructor with expertise in vascular anomalies, genetic skin diseases, and inflammatory skin disorders.
Dr. Lekwuttikarn received her medical degree and pediatric training at Ramathibodi Hospital, Mahidol University, Thailand, and completed subspecialty training in pediatric dermatology at King Chulalongkorn Memorial Hospital in Thailand. She subsequently completed clinical research fellowships at the Children’s Hospital of Philadelphia and Stanford University. Prior to joining Stanford, she served as Chief of Pediatric Dermatology and Assistant Professor at Ramathibodi Hospital.
Her work focuses on translational research and clinical trials developing targeted therapies for complex pediatric skin diseases. -
Anna Lembke, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
BioDr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, and a diplomate of the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine.
In 2016, she published "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives.
Her latest book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller and has been translated into 30 languages. It combines the neuroscience of addiction with the wisdom of recovery to explore the problem of compulsive overconsumption in a dopamine-overloaded world. -
Hendrikus Lemmens
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsClinical Pharmacology of Anesthetics
Morbid Obesity
Impedance Cardiography -
Theodore Leng, MD, MS, FACS
Professor of Ophthalmology (Ophthalmology Research/Clinical Trials) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cell and gene regenerative therapies for macular degeneration, retinitis pigmentosa, Stargardt disease, and other degenerative conditions of the macula and retina. He also has an active program in imaging informatics, oculomics, and deep learning to identify patients who are at risk for eye and systemic disease. The end goal is earlier detection and rapid treatment to maximize outcomes.
-
Marc Leon (aka Hongliang Liang) MD, PhD
Clinical Assistant Professor, Cardiothoracic Surgery
BioMarc Leon (also known as Hongliang Liang), M.D., Ph.D., previously served as Chief Surgeon, Associate Professor of Cardiovascular Surgery, and Director of the Division of Coronary Artery Surgery at Xijing Hospital in Xi'an, China. Currently, he is a Clinical Assistant Professor in the Department of Cardiothoracic Surgery at Stanford Hospital. Dr. Leon is a surgeon member of the Society of Thoracic Surgeons (STS), the International Society of Heart and Lung Transplantation (ISHLT), and the Chinese American Academy of Cardiology (CAAC). His clinical and research expertise includes the surgical management of cardiopulmonary failure, heart valve disease, and ischemic heart disease, along with the application of stem cell therapy for myocardial infarction. Additionally, Dr. Leon is actively engaged in exploring the application of artificial intelligence in the field of cardiovascular diseases.
-
Mary Leonard
Arline and Pete Harman Professor, Professor of Pediatrics (Nephrology), of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.
